A new clinical trial sponsored by Medipol University is set to examine two innovative methods for managing shoulder pain. The study, soon to begin recruitment, will focus on evaluating the efficacy of the interscalene block in comparison to the serratus posterior superior intercostal plane block. The trial aims to improve current postoperative analgesia strategies and provide actionable insights for healthcare professionals managing shoulder pain and disease.
What is this clinical trial about?
The upcoming trial will investigate two specific regional anesthesia methods applied during postoperative care. Focusing on conditions such as shoulder pain and shoulder disease, researchers will compare the effects of the interscalene block and the serratus posterior superior intercostal plane block. Both techniques involve the use of targeted drug interventions to manage pain effectively after surgical interventions.
Study Objectives
This research aims to critically evaluate the performance of these pain management techniques. By doing so, it seeks to answer key questions clinicians face when treating patients with challenging postoperative shoulder pain. Insights from this study may inform guidelines and improve the overall standard of care.
Sponsors and Status
The study is organized and sponsored by Medipol University. Current information indicates that recruitment is not yet underway as of the publication date. Healthcare providers interested in enrolling patients should keep an eye out for updates.
Why is this study important?
Pain management following shoulder surgery remains a significant challenge for clinicians. This trial is critical for identifying methods that ensure maximum efficacy with minimal side effects. It could impact clinical decision-making in both preoperative and postoperative care frameworks.
Potential Benefits
Successful implementation of either block method could:
- Reduce reliance on systemic opioid medications.
- Improve patient comfort and recovery time.
- Offer safer and more targeted alternatives for handling complex pain cases.
Global Relevance
As shoulder pain is a widespread condition, these findings could resonate beyond local healthcare systems and influence international practice guidelines. Clinicians, regulatory bodies, and device manufacturers involved in postoperative care should closely monitor the study’s progress.
Frequently Asked Questions
- When does the trial start?
Recruitment has not begun as of December 2025. Updates will be provided through Medipol University or associated clinical trial platforms. - What are the primary conditions studied?
Shoulder pain and shoulder disease are the focus of this research, alongside postoperative pain management techniques. - Who can participate?
Specific inclusion criteria are not yet published but will likely involve patients undergoing shoulder-related surgery. - Where can I find more information?
Details can be accessed on ClinicalTrials.gov using the identifier link provided below.
Key takeaways
This trial represents a significant stride in improving postoperative care for shoulder pain. By exploring innovative regional anesthesia techniques, the study has the potential to enhance the comfort, safety, and recovery of patients worldwide. Healthcare professionals should keep an eye on these developments to incorporate evidence-based practices for patient care.
Disclaimer
This article is intended for healthcare professionals and clinical teams. It does not constitute legal or medical advice. Always consult official trial documents for specific guidance.
Further details
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07278050?term=medical+device